Tychon Bioscience

About:

Tychon Bioscience is a biotechnology company commercializing adaptive immunotherapy technology.

Website: https://tychonbio.com

Description:

Tychon Bioscience is a biotechnology company commercializing adaptive immunotherapy technology. Its PARs harnesses the power of protein dimerization to produce chemically self-assembling nanorings that form a construct to combine a patient’s T-lymphocytes and a host of cancer-seeking antigens creating various cell therapies with selective anti-tumor capabilities.

Total Funding Amount:

$1.62M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)tychonbio.com

Founders:

Danny J. Cunagin, Troy Kopischke

Number of Employees:

11-50

Last Funding Date:

2019-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai